Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/14491

TDMS Study 88031-06 Pathology Tables

NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01
Route: DOSED WATER                                                                                                Time: 14:32:26

                                                           FINAL/MICE




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  25265-71-8

       Lock Date:  04/20/00

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                     11           11            8            7                                     
    Moribund Sacrifice                                 2            1            4            6                                     
    Accidently Killed                                                                         4                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                37           38           38           32                                     
    Natural Death                                                                             1                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (49)         (49)                                   
      Ulcer                                                                                   1 (2%)                                
   Gallbladder                                        (50)         (50)         (49)         (50)                                   
      Epithelium, Cyst                                 5 (10%)      1 (2%)       1 (2%)       1 (2%)                                
      Epithelium, Cytoplasmic Alteration               1 (2%)                                                                       
   Intestine Small, Jejunum                           (50)         (50)         (50)         (50)                                   
      Epithelium, Hyperplasia, Focal                   1 (2%)                                                                       
      Muscularis, Inflammation, Chronic                                          1 (2%)                                             
      Peyer's Patch, Hyperplasia, Lymphoid                                       2 (4%)       2 (4%)                                
      Peyer's Patch, Inflammation, Acute               1 (2%)                                 1 (2%)                                
      Serosa, Fibrosis                                                           1 (2%)                                             
   Intestine Small, Ileum                             (50)         (50)         (50)         (50)                                   
      Epithelium, Inflammation, Chronic                                          1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                                                1 (2%)                                             
      Angiectasis, Focal                               3 (6%)       1 (2%)       2 (4%)       1 (2%)                                
      Basophilic Focus                                 2 (4%)                    1 (2%)       1 (2%)                                
      Clear Cell Focus                                 5 (10%)      5 (10%)      2 (4%)       8 (16%)                               
      Eosinophilic Focus                              21 (42%)     13 (26%)     16 (32%)     17 (34%)                               
      Hepatodiaphragmatic Nodule                                                              1 (2%)                                
      Infiltration Cellular, Lymphocyte               30 (60%)     39 (78%)     35 (70%)     30 (60%)                               
      Inflammation, Chronic                           36 (72%)     33 (66%)     35 (70%)     34 (68%)                               
      Inflammation, Focal, Suppurative                                           1 (2%)                                             
      Mixed Cell Focus                                14 (28%)     19 (38%)     21 (42%)     15 (30%)                               
      Necrosis, Focal                                  2 (4%)       2 (4%)       2 (4%)       1 (2%)                                
      Vacuolization Cytoplasmic, Focal                 4 (8%)      10 (20%)      9 (18%)     10 (20%)                               
      Sinusoid, Amyloid Deposition                                               1 (2%)                                             
   Mesentery                                          (11)         (18)         (13)         (14)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Artery, Inflammation, Chronic                                                           1 (7%)                                
      Fat, Necrosis                                   11 (100%)    13 (72%)     11 (85%)     13 (93%)                               
      Vein, Thrombosis                                              1 (6%)                                                          
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Inflammation, Granulomatous                                                1 (2%)                                             
      Acinus, Atrophy                                                            1 (2%)       1 (2%)                                
      Acinus, Vacuolization Cytoplasmic, Focal         1 (2%)                                                                       
      Duct, Cyst                                                                              1 (2%)                                
   Salivary Glands                                    (49)         (49)         (49)         (49)                                   
      Atrophy                                                                    1 (2%)                                             
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
      Hyperplasia, Squamous                            4 (8%)       1 (2%)       1 (2%)       2 (4%)                                
      Inflammation, Focal, Suppurative                                                        1 (2%)                                
      Ulcer                                            3 (6%)                    1 (2%)       1 (2%)                                
      Epithelium, Cyst                                                           1 (2%)                                             
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphocyte                             1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)       1 (2%)       1 (2%)                                             
      Mineralization, Focal                            4 (8%)       2 (4%)       5 (10%)                                            
      Ulcer                                                         1 (2%)                    2 (4%)                                
   Tooth                                                                                     (1)                                    
      Malformation                                                                            1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (50)         (50)                                   
      Aorta, Inflammation, Chronic                                                            2 (4%)                                
      Aorta, Mineralization                            1 (2%)       3 (6%)                                                          
   Heart                                              (50)         (50)         (49)         (50)                                   
      Cardiomyopathy                                   1 (2%)                                                                       
      Artery, Inflammation, Chronic                    1 (2%)                                 1 (2%)                                
      Epicardium, Inflammation, Chronic Active                      1 (2%)                                                          
      Myocardium, Inflammation, Chronic Active,                                                                                     
           Focal                                       2 (4%)                                 1 (2%)                                
      Myocardium, Mineralization                       2 (4%)       1 (2%)       1 (2%)       2 (4%)                                
      Valve, Inflammation, Chronic                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (49)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hematopoietic Cell Proliferation                              1 (2%)                                                          
      Hyperplasia, Focal                               1 (2%)       1 (2%)       2 (4%)                                             
      Hypertrophy, Focal                               3 (6%)       3 (6%)       2 (4%)       1 (2%)                                
      Subcapsular, Hyperplasia                        48 (96%)     49 (98%)     49 (100%)    48 (96%)                               
   Adrenal Medulla                                    (50)         (49)         (49)         (50)                                   
      Hyperplasia, Focal                               1 (2%)                    1 (2%)                                             
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                     31 (62%)     29 (58%)     29 (58%)     33 (66%)                               
   Pituitary Gland                                    (49)         (49)         (49)         (49)                                   
      Angiectasis                                      1 (2%)                                                                       
      Pars Distalis, Hyperplasia, Focal                6 (12%)      8 (16%)      6 (12%)      5 (10%)                               
   Thyroid Gland                                      (49)         (48)         (49)         (48)                                   
      Inflammation, Granulomatous                      1 (2%)       1 (2%)                    2 (4%)                                
      Follicle, Cyst                                   1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (48)         (49)         (49)         (50)                                   
      Cyst                                                                                    1 (2%)                                
      Hyperplasia                                                                             1 (2%)                                
      Inflammation, Granulomatous                                   1 (2%)                                                          
   Ovary                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      3 (6%)                    5 (10%)      2 (4%)                                
      Cyst                                            12 (24%)     11 (22%)     15 (30%)     14 (28%)                               
      Hemorrhage                                       2 (4%)                                                                       
      Periovarian Tissue, Infiltration Cellular,                                                                                    
           Lymphocyte                                               1 (2%)                                                          
   Oviduct                                                                                   (1)                                    
      Cyst                                                                                    1 (100%)                              
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)       2 (4%)       1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Endometrium, Hyperplasia, Cystic                38 (76%)     38 (76%)     39 (78%)     39 (78%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Bone Marrow                                        (50)         (49)         (50)         (50)                                   
      Fibrosis                                                      1 (2%)                                                          
      Necrosis, Acute, Focal                           1 (2%)                                                                       
      Vacuolization Cytoplasmic, Focal                 1 (2%)                                                                       
   Lymph Node                                         (5)          (3)          (1)          (2)                                    
      Lumbar, Hematopoietic Cell Proliferation         1 (20%)                                                                      
      Lumbar, Infiltration Cellular, Plasma Cell       2 (40%)                                                                      
      Lumbar, Infiltration Cellular, Histiocyte        1 (20%)                                                                      
      Mediastinal, Congestion                                                    1 (100%)                                           
      Mediastinal, Hyperplasia, Lymphoid                                         1 (100%)                                           
      Mediastinal, Infiltration Cellular, Plasma                                                                                    
          Cell                                         1 (20%)                                                                      
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                   1 (20%)                                                                      
      Mediastinal, Pigmentation, Hemosiderin           1 (20%)                                                                      
      Pancreatic, Inflammation, Granulomatous                                    1 (100%)                                           
      Renal, Hyperplasia, Lymphoid                                               1 (100%)                                           
   Lymph Node, Mandibular                             (48)         (45)         (48)         (48)                                   
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                                                          
   Lymph Node, Mesenteric                             (48)         (48)         (49)         (49)                                   
      Hyperplasia, Lymphoid                                         1 (2%)                    2 (4%)                                
      Infiltration Cellular, Plasma Cell                            1 (2%)                                                          
      Infiltration Cellular, Histiocyte                             1 (2%)                                                          
      Inflammation, Granulomatous                      2 (4%)                    1 (2%)                                             
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Hematopoietic Cell Proliferation                29 (58%)     24 (48%)     25 (50%)     24 (48%)                               
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Capsule, Fibrosis, Focal                                                   1 (2%)                                             
      Lymphoid Follicle, Amyloid Deposition                                      1 (2%)                                             
      Lymphoid Follicle, Atrophy                      12 (24%)     10 (20%)     10 (20%)     12 (24%)                               
      Lymphoid Follicle, Hyperplasia                   7 (14%)      8 (16%)      6 (12%)      7 (14%)                               
   Thymus                                             (49)         (49)         (48)         (50)                                   
      Hyperplasia, Lymphoid                            5 (10%)      1 (2%)       4 (8%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (49)                                   
      Hyperplasia                                                   1 (2%)                    1 (2%)                                
      Duct, Hyperplasia, Squamous                      1 (2%)                                                                       
   Skin                                               (50)         (50)         (50)         (50)                                   
      Ulcer                                                                      1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Epidermis, Cyst                                                            1 (2%)                                             
      Epidermis, Hyperplasia, Focal                                              1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrosis                                         4 (8%)       4 (8%)       4 (8%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (49)         (49)         (50)                                   
      Hydrocephalus                                                                           2 (4%)                                
      Necrosis, Acute, Focal                                                     1 (2%)                                             
      Artery, Meninges, Inflammation, Chronic                                                 1 (2%)                                
      Hypothalamus, Compression                                     1 (2%)                    2 (4%)                                
   Peripheral Nerve                                   (1)                                                                           
      Sciatic, Axon, Degeneration                      1 (100%)                                                                     
   Spinal Cord                                        (1)                                                                           
      Axon, Degeneration                               1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (49)         (50)                                   
      Congestion                                                                              1 (2%)                                
      Hemorrhage, Focal                                1 (2%)       1 (2%)                                                          
      Inflammation, Chronic, Focal                     3 (6%)       2 (4%)       4 (8%)       2 (4%)                                
      Inflammation, Granulomatous                      1 (2%)       3 (6%)                    2 (4%)                                
      Thrombosis                                       3 (6%)                                                                       
      Alveolar Epithelium, Hyperplasia, Focal          3 (6%)       1 (2%)       1 (2%)       1 (2%)                                
      Artery, Inflammation, Chronic                    1 (2%)                                                                       
      Artery, Mineralization                                        1 (2%)                                                          
      Bronchus, Foreign Body                                                                  4 (8%)                                
      Bronchus, Inflammation, Acute                    1 (2%)                                 4 (8%)                                
   Nose                                               (50)         (49)         (50)         (50)                                   
      Inflammation, Acute                                                                     3 (6%)                                
      Inflammation, Suppurative                        1 (2%)                                 1 (2%)                                
      Necrosis, Focal                                  1 (2%)                                                                       
      Glands, Cyst                                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)                                    (2)                                    
      Atrophy                                                                                 1 (50%)                               
      Degeneration                                                                            1 (50%)                               
      Cornea, Inflammation, Chronic                    1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Hydronephrosis                                                             2 (4%)                                             
      Infarct                                          4 (8%)       7 (14%)      9 (18%)      8 (16%)                               
      Inflammation, Focal, Suppurative                                           1 (2%)                                             
      Metaplasia, Osseous                              1 (2%)       3 (6%)                                                          
      Nephropathy                                     12 (24%)      8 (16%)     15 (30%)     12 (24%)                               
      Artery, Inflammation, Chronic                    1 (2%)                    1 (2%)                                             
      Papilla, Necrosis                                                          1 (2%)                                             
      Renal Tubule, Hyperplasia, Focal                              1 (2%)                                                          
      Renal Tubule, Vacuolization Cytoplasmic                                                 1 (2%)                                
   Urinary Bladder                                    (50)         (49)         (49)         (50)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Acute                              1 (2%)                                                                       
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      7            8           10            6                                     
    Moribund Sacrifice                                 3            3            5            9                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                39           39           35           34                                     
    Natural Death                                      1                                                                            
  Missing                                                                                     1                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           49                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)         (49)                                   
      Inflammation, Granulomatous                      1 (2%)                                                                       
   Gallbladder                                        (48)         (48)         (49)         (48)                                   
      Epithelium, Cyst                                              1 (2%)                    2 (4%)                                
      Epithelium, Cytoplasmic Alteration               2 (4%)       1 (2%)                                                          
      Epithelium, Mineralization                                                 1 (2%)                                             
   Intestine Large, Colon                             (50)         (50)         (50)         (49)                                   
      Inflammation, Suppurative                        1 (2%)                                                                       
      Serosa, Inflammation, Granulomatous                           1 (2%)                                                          
   Intestine Large, Rectum                            (50)         (50)         (50)         (49)                                   
      Epithelium, Hyperplasia, Focal                   1 (2%)                                                                       
   Intestine Large, Cecum                             (50)         (50)         (50)         (49)                                   
      Ulcer                                                         1 (2%)                                                          
   Intestine Small, Duodenum                          (50)         (49)         (50)         (49)                                   
      Cyst                                                                                    1 (2%)                                
      Necrosis, Focal                                  1 (2%)                                                                       
      Epithelium, Hyperplasia, Focal                                                          1 (2%)                                
   Intestine Small, Jejunum                           (50)         (50)         (50)         (49)                                   
      Hyperplasia                                                                             1 (2%)                                
      Ulcer                                                                      1 (2%)                                             
      Epithelium, Hyperplasia, Focal                                             1 (2%)                                             
      Peyer's Patch, Hyperplasia, Lymphoid             1 (2%)       1 (2%)       3 (6%)                                             
      Peyer's Patch, Infiltration Cellular, Plasma                                                                                  
          Cell                                                                   1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (49)                                   
      Angiectasis, Focal                                                         2 (4%)       1 (2%)                                
      Basophilic Focus                                 2 (4%)       1 (2%)                    3 (6%)                                
      Clear Cell Focus                                26 (52%)     24 (48%)     31 (62%)     12 (24%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Eosinophilic Focus                              15 (30%)     28 (56%)     18 (36%)     11 (22%)                               
      Fibrosis, Focal                                                            1 (2%)                                             
      Hepatodiaphragmatic Nodule                       1 (2%)                                                                       
      Infiltration Cellular, Polymorphonuclear         1 (2%)                                                                       
      Inflammation, Chronic                           23 (46%)     21 (42%)     20 (40%)     20 (41%)                               
      Mixed Cell Focus                                15 (30%)     20 (40%)     21 (42%)      7 (14%)                               
      Necrosis, Focal                                  7 (14%)      5 (10%)      5 (10%)      5 (10%)                               
      Vacuolization Cytoplasmic, Focal                 3 (6%)       3 (6%)       4 (8%)       2 (4%)                                
      Serosa, Fibrosis                                                                        1 (2%)                                
   Mesentery                                          (8)          (10)         (1)                                                 
      Artery, Inflammation, Chronic                                 1 (10%)                                                         
      Fat, Necrosis                                    7 (88%)      9 (90%)      1 (100%)                                           
   Pancreas                                           (50)         (50)         (50)         (49)                                   
      Fibrosis                                         1 (2%)                                                                       
      Inflammation, Chronic                                         1 (2%)                                                          
      Acinus, Atrophy, Focal                           1 (2%)                                                                       
      Duct, Cyst                                                                              1 (2%)                                
   Salivary Glands                                    (50)         (50)         (50)         (49)                                   
      Atrophy, Focal                                                                          1 (2%)                                
   Stomach, Forestomach                               (50)         (50)         (50)         (49)                                   
      Hyperplasia, Squamous                            2 (4%)                    1 (2%)       3 (6%)                                
      Inflammation, Focal, Suppurative                 2 (4%)                                                                       
      Ulcer                                                                      2 (4%)       2 (4%)                                
   Stomach, Glandular                                 (50)         (50)         (50)         (49)                                   
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Inflammation, Chronic                            3 (6%)                                                                       
      Mineralization, Focal                                         3 (6%)                    2 (4%)                                
      Epithelium, Hyperplasia, Focal                                             2 (4%)                                             
      Epithelium, Inflammation, Focal, Suppurative                  1 (2%)                                                          
   Tooth                                              (26)         (22)         (20)         (7)                                    
      Malformation                                    26 (100%)    22 (100%)    20 (100%)     7 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (50)         (49)                                   
      Aorta, Inflammation, Chronic                     1 (2%)                                                                       
      Pulmonary Artery, Mineralization                              1 (2%)                                                          
   Heart                                              (50)         (50)         (50)         (49)                                   
      Cardiomyopathy                                   3 (6%)                    1 (2%)                                             
      Artery, Inflammation, Chronic                    1 (2%)       1 (2%)                                                          
      Myocardium, Inflammation, Chronic Active,                                                                                     
           Focal                                       2 (4%)       1 (2%)       1 (2%)       1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Myocardium, Mineralization                       2 (4%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (49)                                   
      Hyperplasia, Focal                               7 (14%)      4 (8%)       1 (2%)                                             
      Hypertrophy, Focal                              28 (56%)     24 (48%)     23 (46%)     15 (31%)                               
      Necrosis                                                                   1 (2%)                                             
      Subcapsular, Hyperplasia                        47 (94%)     46 (92%)     44 (88%)     42 (86%)                               
      Zona Fasciculata, Zona Reticularis,                                                                                           
          Vacuolization Cytoplasmic                    1 (2%)                                                                       
   Adrenal Medulla                                    (50)         (49)         (50)         (49)                                   
      Hyperplasia, Focal                                            2 (4%)                                                          
   Islets, Pancreatic                                 (50)         (50)         (50)         (49)                                   
      Hyperplasia                                     40 (80%)     41 (82%)     39 (78%)     43 (88%)                               
   Pituitary Gland                                    (49)         (48)         (49)         (49)                                   
      Pars Distalis, Hyperplasia, Focal                3 (6%)       3 (6%)       2 (4%)       1 (2%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (49)                                   
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Follicle, Cyst                                   1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Peritoneum                                         (1)                                                                           
      Inflammation, Chronic                            1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (49)                                   
      Atrophy                                                                                 1 (2%)                                
      Granuloma Sperm                                  2 (4%)       1 (2%)                    1 (2%)                                
      Inflammation, Chronic                            1 (2%)                                                                       
      Syncytial Alteration                             1 (2%)                                                                       
   Preputial Gland                                    (50)         (50)         (50)         (49)                                   
      Cyst                                            30 (60%)     32 (64%)     34 (68%)     34 (69%)                               
      Cytoplasmic Alteration                                                     1 (2%)                                             
      Inflammation, Chronic                            1 (2%)                                 2 (4%)                                
      Inflammation, Suppurative                        5 (10%)      3 (6%)                                                          
      Bilateral, Cyst                                  1 (2%)                                                                       
   Prostate, NOS                                      (50)         (50)         (50)         (49)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Atrophy                                                                                 1 (2%)                                
      Inflammation, Suppurative                        1 (2%)                                                                       
   Seminal Vesicle                                    (50)         (50)         (50)         (49)                                   
      Atrophy                                                                                 2 (4%)                                
      Cyst                                                          4 (8%)                    1 (2%)                                
      Fibrosis                                                                   1 (2%)                                             
      Hyperplasia                                      1 (2%)       1 (2%)       2 (4%)                                             
      Inflammation, Chronic                                         1 (2%)                                                          
   Testes                                             (50)         (50)         (50)         (49)                                   
      Inflammation, Granulomatous                                                1 (2%)                                             
      Germinal Epithelium, Atrophy                                                            1 (2%)                                
      Interstitial Cell, Hyperplasia, Focal            1 (2%)       2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node, Mandibular                             (47)         (49)         (48)         (47)                                   
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Infiltration Cellular, Megakaryocyte             1 (2%)                                                                       
      Infiltration Cellular, Plasma Cell                            1 (2%)                                                          
   Lymph Node, Mesenteric                             (48)         (50)         (49)         (48)                                   
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Infiltration Cellular, Plasma Cell                            1 (2%)                    1 (2%)                                
      Infiltration Cellular, Histiocyte                                                       1 (2%)                                
      Inflammation, Granulomatous                                                1 (2%)                                             
   Spleen                                             (50)         (50)         (50)         (49)                                   
      Hematopoietic Cell Proliferation                15 (30%)     17 (34%)     14 (28%)     12 (24%)                               
      Lymphoid Follicle, Atrophy                      11 (22%)     12 (24%)     11 (22%)     13 (27%)                               
      Lymphoid Follicle, Hyperplasia                   2 (4%)       1 (2%)       3 (6%)       1 (2%)                                
   Thymus                                             (46)         (45)         (47)         (44)                                   
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (49)                                   
      Hyperkeratosis                                                                          1 (2%)                                
      Ulcer                                                         1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
MUSCULOSKELETAL SYSTEM - CONT                                                                                                       
   Bone                                               (49)         (50)         (50)         (49)                                   
      Fibrosis                                         2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (49)                                   
      Hemorrhage                                                    1 (2%)                                                          
   Peripheral Nerve                                                                          (1)                                    
      Axon, Degeneration                                                                      1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (49)                                   
      Inflammation, Chronic, Focal                                  1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Granulomatous                                   1 (2%)       1 (2%)       1 (2%)                                
      Metaplasia, Focal, Osseous                                                 2 (4%)       1 (2%)                                
      Thrombosis                                       1 (2%)                    1 (2%)                                             
      Alveolar Epithelium, Hyperplasia, Focal          3 (6%)       3 (6%)       4 (8%)       3 (6%)                                
      Artery, Mineralization                                                                  1 (2%)                                
   Nose                                               (50)         (50)         (50)         (49)                                   
      Hyperostosis                                     1 (2%)                                                                       
      Inflammation, Suppurative                                                  1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                             (2)          (1)                                                 
      Cornea, Degeneration                                          1 (50%)                                                         
      Cornea, Inflammation, Chronic                                              1 (100%)                                           
      Cornea, Inflammation, Suppurative                             1 (50%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (49)                                   
      Glomerulosclerosis                                                         1 (2%)                                             
      Hydronephrosis                                                2 (4%)       1 (2%)                                             
      Infarct                                          7 (14%)     14 (28%)     10 (20%)      9 (18%)                               
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic, Focal                                               1 (2%)       1 (2%)                                
      Metaplasia, Osseous                              3 (6%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
NTP Experiment-Test: 88031-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                         DIPROPYLENE GLYCOL                                    Date: 09/26/01    
Route: DOSED WATER                                                                                                Time: 14:32:26    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0.0%         1.0%         2.0%         4.0%                                      
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Nephropathy                                     38 (76%)     37 (74%)     34 (68%)     36 (73%)                               
      Papilla, Necrosis                                2 (4%)                                                                       
      Renal Tubule, Cyst                               2 (4%)       1 (2%)       2 (4%)                                             
      Renal Tubule, Degeneration                                                 1 (2%)                                             
      Renal Tubule, Hyperplasia, Focal                 3 (6%)       4 (8%)       2 (4%)       2 (4%)                                
      Renal Tubule, Vacuolization Cytoplasmic                                    1 (2%)                                             
   Urethra                                            (1)                                                                           
      Inflammation, Suppurative                        1 (100%)                                                                     
   Urinary Bladder                                    (50)         (50)         (50)         (48)                                   
      Inflammation, Suppurative                        1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia, Focal                                1 (2%)                                             
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   13                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------